Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Consultation mode outlook
2.2.2. Application outlook
2.3. Competitive Insights
Chapter 3. U.S. Virtual Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Virtual Care: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Technology Timeline Analysis: Emerging Trends
3.5. Case Study Analysis
Chapter 4. U.S. Virtual Care Market Segment Analysis, By Consultation Mode, 2018-2030 (USD Million)
4.1. Definition and Scope
4.2. Consultation Mode Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. U.S. Virtual Care Market, by Consultation Mode, 2018 to 2030
4.5. Audio
4.5.1. Audio market estimates and forecasts 2018 to 2030, (USD Million)
4.6. Messaging
4.6.1. Messaging market estimates and forecasts 2018 to 2030, (USD Million)
4.7. Video
4.7.1. Video market estimates and forecasts 2018 to 2030, (USD Million)
Chapter 5. U.S. Virtual Care Market Segment Analysis, By Application, 2018-2030 (USD Million)
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. U.S. Virtual Care Market, by Application, 2018 to 2030
5.5. Family Medicine
5.5.1. Family Medicine market estimates and forecasts, 2018 to 2030 (USD million)
5.6. Internal Medicine
5.6.1. Internal Medicine market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Cardiology
5.7.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Pediatrics
5.8.1. Pediatrics market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Endocrionology
5.9.1. Endocrionology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Rheumatology
5.10.1. Rheumatology market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Pulmonology
5.11.1. Pulmonology market estimates and forecasts, 2018 to 2030 (USD Million)
5.12. Others
5.12.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. CVS Health
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. virtuwell.com.
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. MeMD
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. HealthTap, Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. iCliniq
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Teladoc Health Inc.
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. American Well
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. MDLIVE
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Doctor on Demand
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Sesame, Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
List of Tables
Table 1. List of abbreviations
Table 2. List of secondary sources
Table 3. U.S. virtual care market, by consultation mode, 2018 - 2030 (USD Million)
Table 4. U.S. virtual care market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. virtual care market: outlook
Fig. 9 U.S. virtual care competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 U.S. virtual care market driver impact
Fig. 12 U.S. virtual care market restraint impact
Fig. 13 Porter’s Analysis
Fig. 14 PESTLE Analysis
Fig. 15 U.S. virtual care market: Consultation Mode outlook and key takeaways
Fig. 16 U.S. virtual care market: Consultation Mode movement analysis
Fig. 17 Video market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Audio market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Messaging market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 U.S. virtual care market: Application outlook and key takeaways
Fig. 21 U.S. virtual care market: Application movement analysis
Fig. 22 Family Medicine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Internal Medicine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Pediatrics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Endocrionology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Rheumatology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Pulmonology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Heatmap Analysis, 2024